Azurity Pharmaceuticals, Inc. recalls Zenzedi (Dextroamphetamine Sulfate) CII Tablets
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Labeling: Label Mix-up
- Products
-
- Zenzedi (Dextroamphetamine Sulfate) CII Tablets
- Where it was sold
-
USA nationwide
Nationwide
- Units affected
- 4,662 bottles
- About this recall
- Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03